| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/16/2013 | CN102875642A Compounds for enzyme inhibition |
| 01/16/2013 | CN102093468B Method for synthesizing reduced glutathione |
| 01/16/2013 | CN101434645B Synthetic oligopeptide and uses thereof |
| 01/15/2013 | US8354499 Cyanine-based probe\tag-peptide pair fluorescence protein imaging and fluorescence protein imaging methods |
| 01/15/2013 | US8354374 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 01/15/2013 | US8354372 Cyclised alpha-conotoxin peptides |
| 01/15/2013 | CA2489186C Chemical synthesis of reagents for peptide coupling |
| 01/10/2013 | WO2013005045A1 Benzylamine derivatives as inhibitors of plasma kallikrein |
| 01/10/2013 | WO2013004845A1 Cyclic tripeptide mimetics as plasmin inhibitors |
| 01/10/2013 | WO2013004636A1 Stabilized subtilisin composition |
| 01/10/2013 | WO2013004399A1 Anti - amyloidogenic, alpha-helix breaking ultra-small peptide therapeutics |
| 01/10/2013 | WO2013004203A1 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases |
| 01/10/2013 | US20130012686 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane |
| 01/10/2013 | US20130012448 Synthetic peptide amides |
| 01/10/2013 | US20130012430 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/10/2013 | US20130011465 Composition and method for the treatment of diseases affected by apoptosis |
| 01/10/2013 | US20130011419 Cross-linkers and their uses |
| 01/10/2013 | CA2841042A1 Benzylamine derivatives as inhibitors of plasma kallikrein |
| 01/10/2013 | CA2838496A1 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases |
| 01/09/2013 | EP2543676A1 Cyclical tripeptide mimetics |
| 01/09/2013 | EP2542238A1 Compounds for immunoproteasome inhibition |
| 01/09/2013 | CN102869674A Crystalline oxidized glutathione and production method therefor |
| 01/09/2013 | CN102863512A Novel antiviral compound |
| 01/09/2013 | CN102863511A Neotame preparation method |
| 01/09/2013 | CN102863510A N (2)-L-alanyl-L-glutamine synthetic method |
| 01/08/2013 | US8349805 Use of Gonadorelin as a therapeutic agent |
| 01/08/2013 | US8349791 Polypeptides that bind membrane proteins |
| 01/08/2013 | CA2689686C Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof |
| 01/08/2013 | CA2559188C Hyaluronic acid-methotrexate conjugate |
| 01/08/2013 | CA2486838C Organic amine salts of glutamic acid derivatives and their application |
| 01/08/2013 | CA2305681C Apoptosis-related compounds and their use |
| 01/03/2013 | WO2013002329A1 Method for producing lanthionine derivative |
| 01/03/2013 | WO2013002317A1 Solid oxidized glutathione salt and method for producing same |
| 01/03/2013 | WO2013001830A1 Nucleoside antibiotic derivative |
| 01/03/2013 | WO2013001120A1 Chemical process for the selective modification of peptides |
| 01/03/2013 | WO2012098546A3 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
| 01/03/2013 | US20130005943 Methods for Preparing Internally Constrained Peptides and Peptidomimetics |
| 01/03/2013 | US20130005833 Photo-responsive supramolecular hydrogels |
| 01/03/2013 | US20130005663 Smac peptidometics useful as iap inhibitors |
| 01/02/2013 | EP2540721A1 Ghrelin receptor agonist for treatment of dyscrasia |
| 01/02/2013 | EP2540350A1 Combinations of a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitors with other HCV agents |
| 01/02/2013 | EP2540349A1 Pharmaceutical compositions comprising a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitor |
| 01/02/2013 | EP2539358A1 Peptide analogues |
| 01/02/2013 | EP2539333A1 Dimeric iap inhibitors |
| 01/02/2013 | CN102858792A Non-crystalline oxidized glutathione and production method therefor |
| 01/02/2013 | CN102850436A Growth hormone releasing peptides |
| 01/01/2013 | US8344173 Dendritic oligopeptide-grafteded cyclotriphosphazene, a process for the preparation thereof and a drug delivery system containing the same |
| 01/01/2013 | US8344102 Nanoparticle and magnetic resonance imaging contrast agent |
| 01/01/2013 | US8344100 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 01/01/2013 | US8343503 Contiguous overlapping peptides for treatment of birch pollen allergy |
| 01/01/2013 | US8343500 Peptide composition |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 12/27/2012 | WO2012178063A1 Compound and method for modulating opioid receptor activity |
| 12/27/2012 | WO2012175642A1 Peptide prodrugs |
| 12/27/2012 | WO2012031250A3 Compositions for labeling nerves and methods of use |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120329987 Metal Abstraction Peptide (MAP) Tag and Associated Methods |
| 12/27/2012 | US20120329985 Optimal hydolysis conditions of soy protein to produce peptides with lipolysis-stimulating activity and their sequencing and use thereof |
| 12/27/2012 | US20120329730 Aromatic-cationic peptides and uses of same |
| 12/27/2012 | US20120329724 Peptide analogues |
| 12/27/2012 | US20120329721 Means for preventing and treating cellular death and their biological applications |
| 12/27/2012 | US20120329716 Yellow pea seed protein-derived peptides |
| 12/27/2012 | US20120329705 Compounds for proteasome enzyme inhibition |
| 12/27/2012 | US20120329704 Process for the preparation of substituted prolyl peptides and similar peptidomimetics |
| 12/26/2012 | EP2537850A1 Organic compounds |
| 12/26/2012 | EP2537846A1 Organic compounds |
| 12/26/2012 | EP2537534A1 Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems |
| 12/26/2012 | EP2536732A2 Cyclic tetrapeptides and therapeutic applications thereof |
| 12/26/2012 | CN1826333B Diamine derivatives |
| 12/26/2012 | CN102838656A Preparation method of L-alanyl-L-glutamine |
| 12/26/2012 | CN102190705B Synthetic method for Arg-Orn dipeptide |
| 12/26/2012 | CN101311151B Process for the preparation of 3,3-dimethylbutanal |
| 12/25/2012 | US8338380 Use of the peptide RFMWMR as a therapeutic agent |
| 12/25/2012 | US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes |
| 12/20/2012 | WO2012173983A1 Hepatitis c virus inhibitors |
| 12/20/2012 | WO2012173762A1 Cyclic lactadherin peptide mimetics and their uses |
| 12/20/2012 | WO2012171332A1 Macrocyclic heterocyclic compound for inhibiting hepatitis c virus and preparation and use thereof |
| 12/20/2012 | WO2007113356A3 Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions |
| 12/20/2012 | US20120322978 Crosslinking reagents, methods, and compositions for studying protein-protein interactions |
| 12/20/2012 | US20120322748 Novel peptides that enhance tight junction permeability |
| 12/20/2012 | US20120322741 Psma binding ligand-linker conjugates and methods for using |
| 12/20/2012 | US20120322722 Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use |
| 12/20/2012 | US20120322715 Serine hydrolase formulation |
| 12/20/2012 | US20120321583 Protein-Polymer-Drug Conjugates |
| 12/20/2012 | CA2857705A1 Macrocyclic heterocyclic compounds for inhibiting hepatitis c virus and preparation and use thereof |
| 12/20/2012 | CA2839400A1 Hepatitis c virus inhibitors |
| 12/19/2012 | EP2534170A1 Iap bir domain binding compounds |
| 12/19/2012 | EP2534138A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors |
| 12/19/2012 | EP2533813A1 Igf-i poly (ethylene glycol) conjugates |
| 12/19/2012 | CN102834408A Aromatic-cationic peptides and uses of same |
| 12/19/2012 | CN102834389A Dimeric iap inhibitors |
| 12/19/2012 | CN102827248A Tripeptide with Japanese encephalitis virus infection resistance and application thereof |
| 12/19/2012 | CN102827247A New sansanmycins, and their uses as anti-tuberculous medicines |
| 12/19/2012 | CN102827246A Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof |
| 12/19/2012 | CN102827245A N-[2-(3-acetyl-2-oxo-2H-pyridine-1-yl)-acetyl]-L-amino acid, synthetic method and application thereof |
| 12/19/2012 | CN102827244A Method for refining glutathione fermentation broth |
| 12/18/2012 | US8334364 High-molecular weight derivative of nucleic acid antimetabolite |
| 12/18/2012 | US8334253 Cosmetic and dermatological formulations of MNTF peptides |
| 12/18/2012 | CA2508219C Ace inhibitory peptides from plant materials |
| 12/13/2012 | WO2012171020A1 Protein-polymer-drug conjugates |